AARD Kronos AI forecast
A 30-trading-day price forecast for Aardvark Therapeutics Inc. (AARD) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Aardvark Therapeutics Inc. at $5.28 on 2026-12-08, +306.2% from the last close of $1.30 on 2026-10-27. Eight out of ten sampled paths end between $4.78 and $5.51, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of AARD
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $2.05 | $1.64 | $2.63 |
| 2026-11-10 | $4.36 | $3.80 | $4.95 |
| 2026-11-17 | $5.06 | $4.61 | $5.50 |
| 2026-11-24 | $5.21 | $4.86 | $5.70 |
| 2026-12-01 | $5.24 | $4.68 | $5.59 |
| 2026-12-08 | $5.28 | $4.78 | $5.51 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for AARD?
- Kronos AI's median forecast for AARD is $5.28 in 30 trading days, +306.2% from the last close, with a 10–90% range of $4.78 to $5.51.
- Is the AARD Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC